These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 19818082

  • 21. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?
    van Oort IM, Schout BM, Kiemeney LA, Hulsbergen CA, Witjes JA.
    Eur Urol; 2005 Oct; 48(4):572-6. PubMed ID: 16046051
    [Abstract] [Full Text] [Related]

  • 22. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker.
    Yang G, Truong LD, Wheeler TM, Thompson TC.
    Cancer Res; 1999 Nov 15; 59(22):5719-23. PubMed ID: 10582690
    [Abstract] [Full Text] [Related]

  • 23. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
    Rabien A, Burkhardt M, Jung M, Fritzsche F, Ringsdorf M, Schicktanz H, Loening SA, Kristiansen G, Jung K.
    Eur Urol; 2007 May 15; 51(5):1259-66. PubMed ID: 16806661
    [Abstract] [Full Text] [Related]

  • 24. Plasma levels and expression of vascular endothelial growth factor-A in human localized prostate cancer.
    Peyromaure M, Badoual C, Camparo P, Grabar S, Goulvestre C, Fulla Y, Vieillefond A, Mao K, Dinh-Xuan AT.
    Oncol Rep; 2007 Jul 15; 18(1):145-9. PubMed ID: 17549360
    [Abstract] [Full Text] [Related]

  • 25. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
    Vis AN, Noordzij MA, Fitoz K, Wildhagen MF, Schröder FH, van der Kwast TH.
    J Urol; 2000 Dec 15; 164(6):2156-61. PubMed ID: 11061947
    [Abstract] [Full Text] [Related]

  • 26. Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.
    Mirtti T, Laine VJ, Hiekkanen H, Hurme S, Rowe O, Nevalainen TJ, Kallajoki M, Alanen K.
    APMIS; 2009 Mar 15; 117(3):151-61. PubMed ID: 19245588
    [Abstract] [Full Text] [Related]

  • 27. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Bostwick DG.
    J Urol; 1999 Apr 15; 161(4):1229-32. PubMed ID: 10081875
    [Abstract] [Full Text] [Related]

  • 28. Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer.
    Thomas C, Wiesner C, Melchior SW, Schmidt F, Gillitzer R, Thüroff JW, Pfitzenmaier J.
    BJU Int; 2009 Jul 15; 104(1):29-34. PubMed ID: 19154451
    [Abstract] [Full Text] [Related]

  • 29. [Prognostic factors of prostate cancer: usefulness of Ki-67 expression in preoperative biopsies].
    Ojea Calvo A, Mosteiro Cerviño MJ, Domínguez Freire F, Alonso Rodrigo A, Rodríguez Iglesias B, Benavente Delgado J, Barros Rodríguez JM, González Piñeiro A.
    Arch Esp Urol; 2004 Oct 15; 57(8):805-16. PubMed ID: 15560269
    [Abstract] [Full Text] [Related]

  • 30. Analysis of NKX3.1 expression in prostate cancer tissues and correlation with clinicopathologic features.
    Aslan G, Irer B, Tuna B, Yorukoglu K, Saatcioglu F, Celebi I.
    Pathol Res Pract; 2006 Oct 15; 202(2):93-8. PubMed ID: 16413692
    [Abstract] [Full Text] [Related]

  • 31. Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
    Shariat SF, Menesses-Diaz A, Kim IY, Muramoto M, Wheeler TM, Slawin KM.
    Urology; 2004 Jun 15; 63(6):1191-7. PubMed ID: 15183988
    [Abstract] [Full Text] [Related]

  • 32. Decreased immunostaining for macrophage scavenger receptor is associated with poor prognosis of prostate cancer.
    Takayama H, Nonomura N, Nishimura K, Oka D, Shiba M, Nakai Y, Nakayama M, Tsujimura A, Aozasa K, Okuyama A.
    BJU Int; 2009 Feb 15; 103(4):470-4. PubMed ID: 18778349
    [Abstract] [Full Text] [Related]

  • 33. Expression of clusterin in prostate cancer correlates with Gleason score but not with prognosis in patients undergoing radical prostatectomy without neoadjuvant hormonal therapy.
    Miyake H, Muramaki M, Kurahashi T, Yamanaka K, Hara I, Gleave M, Fujisawa M.
    Urology; 2006 Sep 15; 68(3):609-14. PubMed ID: 16979705
    [Abstract] [Full Text] [Related]

  • 34. Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer.
    Prtilo A, Leach FS, Markwalder R, Kappeler A, Burkhard FC, Cecchini MG, Studer UE, Thalmann GN.
    J Urol; 2005 Nov 15; 174(5):1814-8; discussion 1818. PubMed ID: 16217293
    [Abstract] [Full Text] [Related]

  • 35. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
    Villamón-Fort R, Martínez-Jabaloyas JM, Soriano-Sarriá P, Ramos-Soler D, Pastor-Hernández F, Gil-Salom M.
    Urol Int; 2007 Nov 15; 78(4):328-33. PubMed ID: 17495491
    [Abstract] [Full Text] [Related]

  • 36. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
    Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M, Neoptolemos JP, Ke Y, Foster CS.
    Cancer Res; 2000 Dec 15; 60(24):7099-105. PubMed ID: 11156417
    [Abstract] [Full Text] [Related]

  • 37. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.
    J Urol; 2005 Dec 15; 174(6):2181-5. PubMed ID: 16280760
    [Abstract] [Full Text] [Related]

  • 38. Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy.
    Aaltomaa S, Kärjä V, Lipponen P, Isotalo T, Kankkunen JP, Talja M, Mokka R.
    Anticancer Res; 2006 Dec 15; 26(6C):4873-8. PubMed ID: 17214354
    [Abstract] [Full Text] [Related]

  • 39. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation.
    Resnick MB, Gavilanez M, Newton E, Konkin T, Bhattacharya B, Britt DE, Sabo E, Moss SF.
    Hum Pathol; 2005 Aug 15; 36(8):886-92. PubMed ID: 16112005
    [Abstract] [Full Text] [Related]

  • 40. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
    Hermani A, Hess J, De Servi B, Medunjanin S, Grobholz R, Trojan L, Angel P, Mayer D.
    Clin Cancer Res; 2005 Jul 15; 11(14):5146-52. PubMed ID: 16033829
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.